Biblio

Found 4 results

Filters: Keyword is Neoplasm Recurrence, Local [Clear All Filters]

2023

Bauman JE, Saba NF, Roe D, Bauman JR, Kaczmar J, Bhatia A, Muzaffar J, Julian R, Wang S, Bearelly S et al.. 2023. Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.. J Clin Oncol. 41(22):3851-3862.

2020

Kang KH, Lebow ES, Niemierko A, Bussière MR, Dewyer NA, Daly J, McKenna MJ, Lee DJ, Loeffler JS, Busse PM et al.. 2020. Proton therapy for head and neck paragangliomas: A single institutional experience.. Head Neck. 42(4):670-677.

2019

Sun L, Chin R-I, Gastman B, Thorstad W, Yom SS, Reddy CA, Nussenbaum B, Wang SJ, Knackstedt T, Vidimos AT et al.. 2019. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.. JAMA Dermatol. 155(4):442-447.

2017

Naunheim M, Wu X, Ryan WR, Wang SJ, Heaton CM. 2017. Volumetric Growth Rate of Recurrent Pleomorphic Adenoma.. Ann Otol Rhinol Laryngol. 126(7):544-547.